UY32304A - Composición de liberación pulsátil de sildenafil y proceso para prepararla - Google Patents
Composición de liberación pulsátil de sildenafil y proceso para prepararlaInfo
- Publication number
- UY32304A UY32304A UY0001032304A UY32304A UY32304A UY 32304 A UY32304 A UY 32304A UY 0001032304 A UY0001032304 A UY 0001032304A UY 32304 A UY32304 A UY 32304A UY 32304 A UY32304 A UY 32304A
- Authority
- UY
- Uruguay
- Prior art keywords
- sildenafil
- pulsatable
- prepare
- release
- release composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
- A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Gynecology & Obstetrics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
La presente invención se refiere a una composición farmacéutica de sildenafil de liberación pulsátil que comprende una fracción de liberación inmediata que contiene 5 a 100 mg de sildenafil y una fracción de liberación controlada que contiene 25 a 150 mg de sildenafil, en donde la fracción de liberación controlada está compuesto por partículas que contienen (a) un agente superdesintegrante, (b) un recubrimiento formado por al menos un polímero de solubilidad pH-dependiente y al menos un polímero de solubilidad pH-independiente y (c) opcionalmente otros excipientes farmacéuticas. La composición de la presente invención presenta un perfil de disolución más rápido en medio alcalino que en medio ácido, lo que permite obtener formulaciones mejoradas de liberación pulsátil
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/IB2008/003466 WO2010067140A1 (es) | 2008-12-12 | 2008-12-12 | Composicion de liberacion pulsatil de sildenafil y proceso para prepararla |
Publications (1)
Publication Number | Publication Date |
---|---|
UY32304A true UY32304A (es) | 2010-05-31 |
Family
ID=42242382
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UY0001032304A UY32304A (es) | 2008-12-12 | 2009-12-07 | Composición de liberación pulsátil de sildenafil y proceso para prepararla |
Country Status (13)
Country | Link |
---|---|
US (1) | US20110244050A1 (es) |
EP (1) | EP2374460A4 (es) |
AR (1) | AR071970A1 (es) |
BR (1) | BRPI0823356A2 (es) |
CL (1) | CL2009002173A1 (es) |
CR (1) | CR20110322A (es) |
EC (1) | ECSP11011194A (es) |
MX (1) | MX339136B (es) |
NI (1) | NI201100119A (es) |
PA (1) | PA8853801A1 (es) |
PE (1) | PE20100471A1 (es) |
UY (1) | UY32304A (es) |
WO (1) | WO2010067140A1 (es) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013110975A1 (es) * | 2012-01-27 | 2013-08-01 | Siegfried Rhein S.A. De C.V. | Composición de nitazoxanida mejorada y proceso para prepararla |
EA019381B1 (ru) * | 2012-07-20 | 2014-03-31 | Открытое акционерное общество "Химико-фармацевтический комбинат "Акрихин" | Таблетка, содержащая ингибитор фосфодиэстеразы пятого типа, способ ее получения и ее применение |
KR101340733B1 (ko) * | 2012-12-31 | 2013-12-12 | (주) 에프엔지리서치 | 신규한 마이크로그래뉼 제형 |
CA2910865C (en) | 2014-07-15 | 2016-11-29 | Isa Odidi | Compositions and methods for reducing overdose |
WO2017168174A1 (en) * | 2016-04-02 | 2017-10-05 | N4 Pharma Uk Limited | New pharmaceutical forms of sildenafil |
US20190328869A1 (en) | 2016-10-10 | 2019-10-31 | Transgene Sa | Immunotherapeutic product and mdsc modulator combination therapy |
WO2023037394A1 (en) * | 2021-09-13 | 2023-03-16 | Amman Pharmaceutical Industries Company | A pharmaceutical composition of sildenafil and a formulation thereof |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9013750D0 (en) | 1990-06-20 | 1990-08-08 | Pfizer Ltd | Therapeutic agents |
GB9311920D0 (en) * | 1993-06-09 | 1993-07-28 | Pfizer Ltd | Therapeutic agents |
GB9612514D0 (en) | 1996-06-14 | 1996-08-14 | Pfizer Ltd | Novel process |
TR199901564T2 (xx) | 1997-01-06 | 1999-09-21 | Pfizer Inc. | H�zl� ��z�lebilen ve tat-maskesi sa�layan dozaj ispen�iyari formu. |
CA2235642C (en) | 1998-05-15 | 2007-11-13 | Torcan Chemical Ltd. | Processes for preparing sildenafil |
UA67802C2 (uk) | 1998-10-23 | 2004-07-15 | Пфайзер Рісьоч Енд Дівелепмент Компані, Н.В./С.А. | Фармацевтична композиція з контрольованим вивільненням інгібітора цгмф фде-5 (варіанти), спосіб її одержання та спосіб лікування еректильної дисфункції |
US6627223B2 (en) * | 2000-02-11 | 2003-09-30 | Eurand Pharmaceuticals Ltd. | Timed pulsatile drug delivery systems |
WO2002072033A2 (en) * | 2001-03-13 | 2002-09-19 | Penwest Pharmaceuticals Co. | Chronotherapeutic dosage forms containing glucocorticosteroid |
CA2590802A1 (en) * | 2004-12-20 | 2006-06-29 | Collegium Pharmaceutical, Inc. | Pharmaceutical compositions for sleep disorders |
FR2891459B1 (fr) * | 2005-09-30 | 2007-12-28 | Flamel Technologies Sa | Microparticules a liberation modifiee d'au moins un principe actif et forme galenique orale en comprenant |
MX370905B (es) * | 2006-08-31 | 2020-01-09 | Adare Pharmaceuticals Inc | Sistema de distribucion de farmacos, que comprenden soluciones solidas de farmacos debilmente basicos. |
-
2008
- 2008-12-12 WO PCT/IB2008/003466 patent/WO2010067140A1/es active Application Filing
- 2008-12-12 BR BRPI0823356-0A patent/BRPI0823356A2/pt not_active Application Discontinuation
- 2008-12-12 EP EP08878690.0A patent/EP2374460A4/en not_active Withdrawn
- 2008-12-12 US US13/139,261 patent/US20110244050A1/en not_active Abandoned
- 2008-12-12 MX MX2011005752A patent/MX339136B/es active IP Right Grant
-
2009
- 2009-05-29 AR ARP090101956A patent/AR071970A1/es unknown
- 2009-12-07 PE PE2009001294A patent/PE20100471A1/es not_active Application Discontinuation
- 2009-12-07 UY UY0001032304A patent/UY32304A/es not_active Application Discontinuation
- 2009-12-11 PA PA20098853801A patent/PA8853801A1/es unknown
- 2009-12-11 CL CL2009002173A patent/CL2009002173A1/es unknown
-
2011
- 2011-06-10 NI NI201100119A patent/NI201100119A/es unknown
- 2011-06-10 CR CR20110322A patent/CR20110322A/es unknown
- 2011-07-11 EC EC2011011194A patent/ECSP11011194A/es unknown
Also Published As
Publication number | Publication date |
---|---|
EP2374460A4 (en) | 2013-08-21 |
MX339136B (es) | 2016-05-13 |
AR071970A1 (es) | 2010-07-28 |
NI201100119A (es) | 2012-08-03 |
PE20100471A1 (es) | 2010-07-22 |
CL2009002173A1 (es) | 2010-04-09 |
ECSP11011194A (es) | 2011-09-30 |
BRPI0823356A2 (pt) | 2015-06-16 |
PA8853801A1 (es) | 2010-07-27 |
US20110244050A1 (en) | 2011-10-06 |
EP2374460A1 (en) | 2011-10-12 |
CR20110322A (es) | 2011-10-25 |
WO2010067140A1 (es) | 2010-06-17 |
MX2011005752A (es) | 2011-08-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NI201100119A (es) | Composición de liberación pulsatil de sildenafil y proceso para prepararla. | |
ES2524320T3 (es) | Composición para la prevención o el tratamiento de enfermedad asociada con trombo o émbolo | |
AR054114A1 (es) | Composiciones farmaceuticas que comprenden imatinib y un retardador de la liberacion | |
WO2008124617A3 (en) | Rapidly dissolving pharmaceutical compositions comprising pullulan | |
ES2556585T3 (es) | Composiciones que comprenden sulfato de salbutamol | |
AR050717A1 (es) | Composiciones farmaceuticas | |
TN2014000441A1 (en) | A delayed release drug formulation | |
CL2015003072A1 (es) | Formulaciones de liberación prolongada de colchicina y métodos de uso de las mismas. | |
CR10975A (es) | Formulaciones para el tratamiento del cancer | |
MX2009004439A (es) | Composicion de ibuprofeno. | |
ES2526606T3 (es) | Composición farmacéutica sólida que comprende amlodipina y losartán | |
BR112012033077B8 (pt) | Composição farmacêutica para administração intravenosa, uso de uma composição farmacêutica, e, kit | |
CL2007002331A1 (es) | Composicion oral solida que comprede uno o mas farmacos antirretrovirales y al menos un polimero insoluble en agua, en relacion aproximadamente 1:1 hasta 1:6; proceso de elaboracion; y uso para el tratamiento del vih. | |
UY29395A1 (es) | Formulación de medicamentos conteniendo vardenafilo. | |
AR067084A1 (es) | Dispersion solida que contiene revaprazan y procedimiento para la preparacion de la misma. composicion farmaceutica. | |
MX2010005013A (es) | Composiciones intranasales. | |
CU20090200A7 (es) | Una composición de liberación prolongada que comprende un derivado de somatostatina en micropartículas | |
UY29989A1 (es) | Composiciones farmacéuticas de agentes hipnoticos de accion corta en forma de liberación modificada y los procedimientos para preparar dichas formulaciones | |
PH12018500304B1 (en) | A delayed release drug formulation | |
CO6390108A2 (es) | Composición de liberación pulsatil de sildenafil y proceso para prepararla | |
DOP2011000181A (es) | Composicion de liberacion pulsatil de sildenafil y proceso para prepararla | |
EA201170583A1 (ru) | Новая композиция для лечения эссенциальной тромбоцитемии | |
ECSP078010A (es) | Formulación de liberación prolongada de principios activos que presentan una solubilidad dependiente del ph | |
GT201100159A (es) | Composicion de liberación pulsatil de sildenafil y proceso para prepararla | |
WO2020053658A3 (en) | Non-aqueous chemotherapeutic solutions for oral dosage |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
109 | Application deemed to be withdrawn |
Effective date: 20210204 |